We came across a bullish thesis on Amgen Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.'s share was trading at $325.54 as of January 12th. AMGN’s trailing and forward P/E were 25.18 and 14.79 respectively according to Yahoo Finance.
[caption id="attachment_522048" align="aligncenter" width="611"]Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide and has seen a steady recovery in 2025, with shares...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.